Skip to main content

Advertisement

SpringerLink
Log in

Influence of Isolated Tumor Cells in Sentinel Nodes on Outcome in Small, Node-Negative (pT1N0M0) Breast Cancer

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the prognostic significance of isolated tumor cells found on sentinel node biopsy.

Methods

The study is based on a prospectively followed up cohort of 1,865 consecutive patients diagnosed with pT1 (tumor size ≤20 mm) breast cancer in one university breast unit between February 2001 and August 2005. Of the 1,390 patients who received no neoadjuvant therapy and who underwent sentinel node biopsy, 63 had isolated tumor cells in the sentinel nodes (stage pT1N0i + M0, verified by axillary node dissection) and 868 did not (pT1N0i − M0). Median follow-up time was 55 months.

Results

Patients with pN0i+ disease received systemic adjuvant therapies more often than those with pN0i− disease (87 versus 51%; P < 0.0001). There was no significant difference between the groups in terms of 5-year recurrence-free survival (90.3 versus 93.2%, respectively; P = 0.32) or overall survival, but patients with pN0i+ cancer had less favorable 5-year breast-cancer-specific survival (95.2 versus 98.4%; P = 0.035) than those with pN0i− cancer, and they were more frequently diagnosed with distant metastases from breast cancer during the first 5 years of follow-up (8.1 versus 1.9%, respectively; P = 0.001). Some conventional prognostic factors, such as histological grade, steroid hormone receptor status, and cell proliferation rate, were more strongly associated with outcome than was pN0i status.

Conclusions

The findings suggest that presence of isolated tumor cells in the sentinel nodes is an adverse prognostic factor in early breast cancer, but its prognostic significance in association with standard factors may be limited.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg. 1985;202:702–7.

    Article  CAS  PubMed  Google Scholar 

  2. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet. 1999;354:896–900.

    Article  CAS  PubMed  Google Scholar 

  3. Dowlatshahi K, Fan M, Anderson JM, Bloom KJ. Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol. 2001;8:675–81.

    Article  CAS  PubMed  Google Scholar 

  4. Gray RJ, Cox CE, Reintgen DS. Importance of missed axillary micrometastases in breast cancer patients. Breast J. 2001;7:303–7.

    Article  CAS  PubMed  Google Scholar 

  5. International (Ludwig) Breast Cancer Study Group. Occult axillary lymph-node micrometastases in breast cancer. Lancet. 1990; 336:434–5.

    Article  Google Scholar 

  6. Wilkinson EJ, Hause LL, Hoffman RG, et al. Occult axillary lymph node metastases in invasive breast carcinoma: characteristics of the primary tumor and significance of the metastases. Pathol Annu. 1982;17 Pt 2:67–91.

    PubMed  Google Scholar 

  7. Cody HS,3rd, Borgen PI, Tan LK. Redefining prognosis in node-negative breast cancer: can sentinellymph node biopsy raise the threshold for systemic adjuvant therapy? Ann Surg Oncol. 2004;11:227S–30S.

    PubMed  Google Scholar 

  8. Sobin H, Wittekind C. UICC TNM classification of malignant tumours, 6th ed. New York: Wiley; 2002.

    Google Scholar 

  9. Colleoni M, Rotmensz N, Peruzzotti G, et al. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol. 2005;23:1379–89.

    Article  PubMed  Google Scholar 

  10. Kuijt GP, Voogd AC, van de Poll-Franse LV, Scheimans LJEE, van Beek MWPM, Roumen RMH. The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol. 2005;31:500–5.

    Article  CAS  PubMed  Google Scholar 

  11. Chen SL, Hoehne FM, Giuliano AE. The prognostic significance of micrometastases in breast cancer: A SEER population-based analysis. Ann Surg Oncol. 2007;14:3378–84.

    Article  PubMed  Google Scholar 

  12. Cox CE, Kiluk JV, Riker AI, et al. Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg. 2008;206:261–8.

    Article  PubMed  Google Scholar 

  13. Cobardhan PD, Elias SG, Madsen EVE, Bongers V, Ruitenberg HJM, Perre CI, et al. Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study. Ann Oncol. 2009;20:41–8.

    Article  Google Scholar 

  14. Querzoli P, Pedriali M, Rinaldi R, et al. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients. Clin Cancer Res. 2006;12:6696–701.

    Article  CAS  PubMed  Google Scholar 

  15. Tan LK, Giri D, Hummer AJ, et al. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol. 2008;26:1803–9.

    Article  PubMed  Google Scholar 

  16. Pugliese MS, Beatty JD, Tickman RJ, et al. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i +) and pN1mi categories. Ann Surg Oncol. 2009;16:113–20.

    Article  PubMed  Google Scholar 

  17. Hansen NM, Ye X, Grube BJ, Giuliano AE. Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. Arch Surg. 2004;139:634–9.

    Article  PubMed  Google Scholar 

  18. Newman EL, Kahn A, Diehl KM, et al. Does the method of biopsy affect the incidence of sentinel lymph node metastases? Breast J. 2006;12:53–7.

    Article  PubMed  Google Scholar 

  19. Diaz NM, Cox CE, Ebert M, et al. Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am J Surg Pathol. 2004;28:1641–5.

    Article  PubMed  Google Scholar 

  20. Bleiweiss IJ, Nagi CS, Jaffer S. Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J Clin Oncol. 2006;24:2013–8.

    Article  PubMed  Google Scholar 

  21. Leikola JP, Toivonen TS, Krogerus LA, von Smitten KAJ. Rapid Immunohistochemistry enhances the intraoperative diagnosis of sentinel lymph node metastases in invasive lobular breast carcinoma. Cancer. 2005;104:14–9.

    Article  PubMed  Google Scholar 

  22. Tavassoli FA, Devilee P, editors. Pathology and genetics of tumours of the breast and female genital organs. In: World Health Organization classification of tumours. Lyon: IARC; 2003.

  23. Joensuu H, Kellokumpu-Lehtinen P, Bono P, et al. Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. N Engl J Med. 2006;354:809–20.

    Article  CAS  PubMed  Google Scholar 

  24. Teppo L, Pukkala E, Saxén E. Multiple cancer—an epidemiologic exercise in Finland. J Natl Cancer Inst. 1985;75:207–17.

    CAS  PubMed  Google Scholar 

  25. Joensuu H, Lehtimäki T, Holli K, et al. Risk for distant recurrence of breast cancer detected by mammography screening or other means. JAMA 2004;292:1064–73.

    Article  CAS  PubMed  Google Scholar 

  26. Langer I, Guller U, Hsu-Schmitz SF, et al. Sentinel lymph node biopsy is associated with improved survival compared to level I&II axillary lymph node dissection in node negative breast cancer patients. Eur J Surg Oncol 2009;805–13.

  27. van Deurzen CHM, de Boer M, Monninkhof EM, Bult P, van der Wall E, Tjan-Heinen VCG, et al. Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst 2008;100:1574–80.

    Article  PubMed  Google Scholar 

  28. Houvenaeghel G, Nos C, Mignotte H, et al. Micrometastases in sentinel lymph node in a multicentric study: predictive factors of nonsentinel lymph node involvement—Groupe Des Chirurgiens De La Federatation Des Centres De Lutte Contre De Cancer. J Clin Oncol. 2006;24:1814–22.

    Article  PubMed  Google Scholar 

  29. Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer. 2001;92:1378–84.

    Article  CAS  PubMed  Google Scholar 

  30. de Mascarel I, MacGrogan G, Debled M, Brouste V, Mauriac L. Distinction between isolated tumor cells and micrometastases in breast cancer. Is it reliable and useful? Cancer. 2008;112:1672–8.

    Article  PubMed  Google Scholar 

  31. Joensuu H, Toikkanen S. Cured of breast cancer. J Clin Oncol. 1995;13:62–9.

    CAS  PubMed  Google Scholar 

  32. De Boer M, van Deurzen CH, van Dijck JA, et al. Micrometastases and isolated tumor cells: relevant and robust or rubbish? (MIRROR): preliminary results of the MIRROR study from the Dutch breast cancer trialists, group (BOOG). Cancer Res. 2009;69:70s.

    Google Scholar 

  33. De Boer M, van Deurzen CH, van Dijck JA, et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med. 2009;361:653–63.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

The study was supported by grants from the Helsinki University Hospital Research Fund, Cancer Society of Finland, Sigrid Juselius Foundation, and Academy of Finland.

Disclosures

The authors have no potential conflicts of interest.

Author information

Authors and Affiliations

  1. Breast Surgery Unit, Helsinki University Central Hospital, Helsinki, Finland

    Marjut H. K. Leidenius MD, PhD & Jaana H. Vironen MD, PhD

  2. Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland

    Päivi S. Heikkilä MD, PhD

  3. Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland

    Heikki Joensuu MD, PhD

Authors
  1. Marjut H. K. Leidenius MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaana H. Vironen MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Päivi S. Heikkilä MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heikki Joensuu MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marjut H. K. Leidenius MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leidenius, M.H.K., Vironen, J.H., Heikkilä, P.S. et al. Influence of Isolated Tumor Cells in Sentinel Nodes on Outcome in Small, Node-Negative (pT1N0M0) Breast Cancer. Ann Surg Oncol 17, 254–262 (2010). https://doi.org/10.1245/s10434-009-0723-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-009-0723-y

Keywords

Search

Navigation